Glen Santangelo
Stock Analyst at Barclays
(3.78)
# 2,006
Out of 5,081 analysts
443
Total ratings
52.8%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 13,043 → ILA 14,596 | ILA 12,320 | +18.47% | 5 | Oct 15, 2026 | |
| VTRS Viatris | Reiterated: Buy | $22 | $18.00 | +22.22% | 15 | Oct 15, 2026 | |
| CTEV Claritev | Reiterated: Buy | $40 | $23.50 | +70.21% | 6 | Oct 13, 2026 | |
| MDLN Medline | Reiterated: Buy | $45 → $43 | $34.09 | +26.14% | 8 | Oct 9, 2026 | |
| PHR Phreesia | Reiterated: Hold | $10 → $11 | $12.70 | -13.39% | 22 | Oct 9, 2026 | |
| LGND Ligand Pharmaceuticals | Initiated Coverage: Buy | $345 | $303.53 | +13.66% | 1 | Sep 25, 2026 | |
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $20 | $20.38 | -1.86% | 6 | Sep 21, 2026 | |
| ALVO Alvotech | Upgraded: Buy | $4 → $8 | $4.58 | +74.67% | 7 | Sep 16, 2026 | |
| WAY Waystar Holding | Downgraded: Hold | $27 → $30 | $28.85 | +3.99% | 9 | Sep 15, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $100 | $72.61 | +37.72% | 8 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $1.08 | -7.41% | 11 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.52 | +33.21% | 11 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $11 | $9.43 | +16.65% | 18 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $27 | $33.39 | -19.14% | 23 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 → $4 | $3.54 | +12.99% | 16 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $35 | $27.71 | +26.31% | 24 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $23 | $25.14 | -8.51% | 11 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $275 | $249.57 | +10.19% | 26 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $925 → $1,000 | $1,000.77 | -0.08% | 16 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $23.60 | +35.59% | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $81.03 | +4.90% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 | $331.00 | +5.74% | 17 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $800 → $710 | $560.38 | +26.70% | 3 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $154.51 | +29.44% | 15 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $100 | $84.96 | +17.70% | 17 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $43 | $34.47 | +24.75% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $9.81 | $9.03 | +8.59% | 16 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7.5 → $8 | $13.75 | -41.82% | 5 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $29 | $28.97 | n/a | 14 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 → $130 | $103.97 | n/a | 23 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $8 | $6.34 | n/a | 25 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $44 | $36.42 | n/a | 11 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $5.74 | n/a | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $22.96 | n/a | 5 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $68.20 | n/a | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $30 | $3.53 | n/a | 3 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $9.60 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $2.5 | $0.000001 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $5.5 | $69.45 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $10.20 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $1.69 | n/a | 5 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $138 | $0.0001 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $15 → $6 | $13.57 | n/a | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $93.47 | n/a | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $17.29 | n/a | 1 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $72 | $241.89 | n/a | 2 | Mar 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $328.95 | n/a | 3 | Mar 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2173 | n/a | 2 | Mar 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 → $15 | $4.95 | n/a | 2 | Nov 7, 2014 |
Teva Pharmaceutical Industries Limited
Oct 15, 2026
Reiterated: Buy
Price Target: ILA 13,043 → ILA 14,596
Current: ILA 12,320
Upside: +18.47%
Viatris
Oct 15, 2026
Reiterated: Buy
Price Target: $22
Current: $18.00
Upside: +22.22%
Claritev
Oct 13, 2026
Reiterated: Buy
Price Target: $40
Current: $23.50
Upside: +70.21%
Medline
Oct 9, 2026
Reiterated: Buy
Price Target: $45 → $43
Current: $34.09
Upside: +26.14%
Phreesia
Oct 9, 2026
Reiterated: Hold
Price Target: $10 → $11
Current: $12.70
Upside: -13.39%
Ligand Pharmaceuticals
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $345
Current: $303.53
Upside: +13.66%
Amneal Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $20
Current: $20.38
Upside: -1.86%
Alvotech
Sep 16, 2026
Upgraded: Buy
Price Target: $4 → $8
Current: $4.58
Upside: +74.67%
Waystar Holding
Sep 15, 2026
Downgraded: Hold
Price Target: $27 → $30
Current: $28.85
Upside: +3.99%
ANI Pharmaceuticals
Aug 25, 2026
Reiterated: Buy
Price Target: $100
Current: $72.61
Upside: +37.72%
Aug 21, 2026
Reiterated: Sell
Price Target: $1
Current: $1.08
Upside: -7.41%
Aug 21, 2026
Reiterated: Buy
Price Target: $30
Current: $22.52
Upside: +33.21%
Aug 21, 2026
Reiterated: Sell
Price Target: $9 → $11
Current: $9.43
Upside: +16.65%
Aug 20, 2026
Reiterated: Hold
Price Target: $20 → $27
Current: $33.39
Upside: -19.14%
Aug 20, 2026
Reiterated: Sell
Price Target: $3 → $4
Current: $3.54
Upside: +12.99%
Aug 20, 2026
Reiterated: Buy
Price Target: $39 → $35
Current: $27.71
Upside: +26.31%
Aug 18, 2026
Reiterated: Hold
Price Target: $20 → $23
Current: $25.14
Upside: -8.51%
Aug 18, 2026
Reiterated: Buy
Price Target: $275
Current: $249.57
Upside: +10.19%
Aug 18, 2026
Reiterated: Buy
Price Target: $925 → $1,000
Current: $1,000.77
Upside: -0.08%
Aug 17, 2026
Reiterated: Buy
Price Target: $32
Current: $23.60
Upside: +35.59%
Aug 17, 2026
Reiterated: Hold
Price Target: $85
Current: $81.03
Upside: +4.90%
Aug 13, 2026
Reiterated: Buy
Price Target: $350
Current: $331.00
Upside: +5.74%
Aug 11, 2026
Reiterated: Buy
Price Target: $800 → $710
Current: $560.38
Upside: +26.70%
Aug 5, 2026
Reiterated: Buy
Price Target: $200
Current: $154.51
Upside: +29.44%
Aug 5, 2026
Reiterated: Buy
Price Target: $86 → $100
Current: $84.96
Upside: +17.70%
Aug 5, 2026
Reiterated: Buy
Price Target: $46 → $43
Current: $34.47
Upside: +24.75%
Jun 3, 2026
Rated: Hold
Price Target: $9.81
Current: $9.03
Upside: +8.59%
Feb 24, 2026
Reiterated: Sell
Price Target: $7.5 → $8
Current: $13.75
Upside: -41.82%
Jul 21, 2025
Reiterated: Buy
Price Target: $28 → $29
Current: $28.97
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: $118 → $130
Current: $103.97
Upside: n/a
Apr 21, 2025
Reiterated: Hold
Price Target: $10 → $8
Current: $6.34
Upside: n/a
Apr 8, 2025
Reiterated: Buy
Price Target: $50 → $44
Current: $36.42
Upside: n/a
Mar 19, 2025
Reiterated: Buy
Price Target: $16 → $13
Current: $5.74
Upside: n/a
Mar 17, 2025
Reiterated: Buy
Price Target: $40
Current: $22.96
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $58
Current: $68.20
Upside: n/a
Jan 6, 2025
Reiterated: Buy
Price Target: $12 → $30
Current: $3.53
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $9.60
Upside: n/a
Oct 20, 2022
Initiated Coverage: Hold
Price Target: $2.5
Current: $0.000001
Upside: n/a
Oct 20, 2022
Initiated Coverage: Hold
Price Target: $5.5
Current: $69.45
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $10.20
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $28
Current: $1.69
Upside: n/a
Mar 4, 2022
Reiterated: Hold
Price Target: $9 → $138
Current: $0.0001
Upside: n/a
Dec 1, 2021
Initiated Coverage: Hold
Price Target: $15 → $6
Current: $13.57
Upside: n/a
Mar 17, 2021
Downgraded: Hold
Price Target: n/a
Current: $93.47
Upside: n/a
Oct 2, 2019
Reiterated: Buy
Price Target: $21
Current: $17.29
Upside: n/a
Mar 16, 2016
Initiated Coverage: Hold
Price Target: $72
Current: $241.89
Upside: n/a
Mar 16, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $328.95
Upside: n/a
Mar 2, 2016
Rated: Hold
Price Target: n/a
Current: $0.2173
Upside: n/a
Nov 7, 2014
Initiated Coverage: Buy
Price Target: $18 → $15
Current: $4.95
Upside: n/a